Clinical Trials
25 trialsNovel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
AstraZeneca
Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
Sun Yat-sen University
Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer
Shandong Cancer Hospital and Institute
CLEAR-03
Fudan University
FUDOSE
UNICANCER
CIME
Centre Leon Berard
LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases
First Affiliated Hospital of Zhejiang University
TRIUNITE-08
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer
Universitätsmedizin Mannheim
Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer
Henan Cancer Hospital
NePHera
Peking Union Medical College Hospital
To Explore the Efficacy of Sintilimab Combined With Bevacizumab in Rectal Cancer
Xijing Hospital of Digestive Diseases
Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer
Tang-Du Hospital
REVISE
West China Hospital
Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients
Zhejiang Cancer Hospital
A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)
Tianjin Medical University Cancer Institute and Hospital
ADAGE
Federation Francophone de Cancerologie Digestive
AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer
Harbin Medical University
SUNRISE
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC
Peking University
Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer
Sun Yat-sen University
EXPLORING
The First Affiliated Hospital with Nanjing Medical University
Perioperative FLOT vs Adjuvant XELOX for CA Stomach
Chinese University of Hong Kong
Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation
Sun Yat-sen University